Yosr Hicheri

Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i>

Mark J. Levis, Mehdi Hamadani, Brent R. Logan et al. · Journal of Clinical Oncology · 2024 · 185 citations · Full text

Medicine, Hematology, Pharmacotherapy +11

CD4 ⁺ CD25 ⁺ Regulatory T Cell Depletion Improves the Graft-Versus-Tumor Effect of Donor Lymphocytes After Allogeneic Hematopoietic Stem Cell Transplantation

Sébastien Maury, François M. Lemoine, Yosr Hicheri et al. · Science Translational Medicine · 2010 · 142 citations

Life Sciences, Hematology, Immunology +14

Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies

Alexandre Alanio, Emilie Sitterlé, M. Liance et al. · Journal of Antimicrobial Chemotherapy · 2010 · 119 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

Real-life experience with CPX-351 and impact on the outcome of high-risk AML patients: a multicentric French cohort

Edmond Chiche, Ramy Rahmé, Sarah Bertoli et al. · Blood Advances · 2021 · 112 citations · Full text

Medicine, Oncology, Pharmacology +17

Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis

Catherine Cordonnier, Françoise Botterel, R. Ben Amor et al. · Clinical Microbiology and Infection · 2008 · 111 citations

Life Sciences, Hematology, Immunology +14